US Patent Issued to Relay Therapeutics, D. E. Shaw Research on March 17 for "Substituted pyrrolo[3,4-bpyridines as PI3K-Alpha inhibitors" (American, Canadian Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,581,252, issued on March 17, was assigned to Relay Therapeutics Inc. (Cambridge, Mass.) and D. E. Shaw Research LLC (New York).

"Substituted pyrrolo[3,4-bpyridines as PI3K-Alpha inhibitors" was invented by Alessandro Boezio (Cambridge, Mass.), Lucian V. Dipietro (Cambridge, Mass.), Hakan Gunaydin (Cambridge, Mass.), Thomas H. McLean (Cambridge, Mass.), Levi Charles Thomas Pierce (Cambridge, Mass.), Fabrizio Giordanetto (New York), Yakov Pechersky (New York), Megan Bertrand-Laperle (Montreal), Alexandre Larivee (Montreal), Kashif Tanveer (Montreal), Michael Paul DeNinno (Gales Ferry, Conn.) and Tarek Mohamed (Montreal).

According to the abstract* released by the U.S. Patent & Tradema...